Related Experiment Video
Updated: May 8, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Altered PKA modulation in the Na(v)1.1 epilepsy variant I1656M
1State Key Laboratory of Medical Neurobiology, Shanghai Medical College and Institutes of Brain Science, Fudan University, Shanghai, China.
Protein kinase A (PKA) signaling impacts sodium channel function in Genetic Epilepsy with Febrile Seizures plus (GEFS(+)). Altered PKA responses in mutant channels may contribute to abnormal neuronal excitability and epilepsy development.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Genetic Epilepsy with Febrile Seizures plus (GEFS(+)) is an inherited epilepsy often linked to SCN1A gene mutations.
- Protein kinases modulate sodium channel function, but their role in GEFS(+) mutant channels is poorly understood.
Purpose of the Study:
- To investigate the impact of protein kinases, specifically PKA and PKC, on the SCN1A GEFS(+) I1656M mutant sodium channel.
- To analyze how these kinase interactions affect channel properties and neuronal excitability.
Main Methods:
- Whole-cell patch-clamp electrophysiology was used to study sodium current properties.
- A computational neuron model was employed to assess the impact on neuronal excitability.
Main Results:
- PKA inhibition significantly decreased sodium current amplitude in I1656M mutant channels, while PKC inhibition had no effect.
- PKA activator responses for voltage-dependent activation and fast inactivation were abolished in the mutant channels.
- Computational modeling indicated that altered PKA-mediated gating in mutant channels affects neuronal excitability.
Conclusions:
- The GEFS(+) I1656M mutation alters the channel's response to PKA signaling.
- Dysregulated PKA signaling in mutant sodium channels may disrupt neuronal electrical balance, contributing to epilepsy.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

